These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29532881)

  • 41. The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma.
    Gravina GL; Mancini A; Marampon F; Colapietro A; Delle Monache S; Sferra R; Vitale F; Richardson PJ; Patient L; Burbidge S; Festuccia C
    J Hematol Oncol; 2017 Jan; 10(1):5. PubMed ID: 28057017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sunitinib mesylate inhibits proliferation of human colonic stromal fibroblasts in vitro and in vivo.
    Wang ZH; Li Q; Ruan SQ; Xiao Q; Liu Y; Hu YT; Hu LF; Chen HY; Zheng S; Zhang SZ; Ding KF
    J Zhejiang Univ Sci B; 2014 Aug; 15(8):701-12. PubMed ID: 25091988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The multi-targeted kinase inhibitor sunitinib induces apoptosis in colon cancer cells via PUMA.
    Sun J; Sun Q; Brown MF; Dudgeon C; Chandler J; Xu X; Shu Y; Zhang L; Yu J
    PLoS One; 2012; 7(8):e43158. PubMed ID: 22912816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.
    Piao Y; Park SY; Henry V; Smith BD; Tiao N; Flynn DL; de Groot JF
    Neuro Oncol; 2016 Sep; 18(9):1230-41. PubMed ID: 26965451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sunitinib enhances antitumor effects against chemotherapy-resistant bladder cancer through suppression of ERK1/2 phosphorylation.
    Takeuchi A; Eto M; Shiota M; Tatsugami K; Yokomizo A; Kuroiwa K; Itsumi M; Naito S
    Int J Oncol; 2012 May; 40(5):1691-6. PubMed ID: 22344606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer.
    Lu J; Li G; He K; Jiang W; Xu C; Li Z; Wang H; Wang W; Wang H; Teng X; Teng L
    J Transl Med; 2015 Feb; 13():42. PubMed ID: 25638174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-MET.
    Mezquita B; Pineda E; Mezquita J; Mezquita P; Pau M; Codony-Servat J; Martínez-Balibrea E; Mora C; Maurel J; Mezquita C
    Mol Carcinog; 2016 May; 55(5):411-9. PubMed ID: 25647613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness.
    Pagani E; Ruffini F; Antonini Cappellini GC; Scoppola A; Fortes C; Marchetti P; Graziani G; D'Atri S; Lacal PM
    Int J Oncol; 2016 Apr; 48(4):1581-9. PubMed ID: 26846845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation.
    Roth L; Prahst C; Ruckdeschel T; Savant S; Weström S; Fantin A; Riedel M; Héroult M; Ruhrberg C; Augustin HG
    Sci Signal; 2016 Apr; 9(425):ra42. PubMed ID: 27117252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Establishment of a novel experimental model of human angiosarcoma and a VEGF-targeting therapeutic experiment.
    Hoshina D; Abe R; Yoshioka N; Saito N; Hata H; Fujita Y; Aoyagi S; Shimizu H
    J Dermatol Sci; 2013 May; 70(2):116-22. PubMed ID: 23522954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumors.
    Voce P; D'Agostino M; Moretti S; Sponziello M; Rhoden K; Calcinaro F; Tamburrano G; Tallini G; Puxeddu E; Filetti S; Russo D; Durante C
    Oncol Rep; 2011 Nov; 26(5):1075-80. PubMed ID: 21850379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of chronic stress on anti-angiogenesis of sunitinib in colorectal cancer models.
    Liu J; Deng GH; Zhang J; Wang Y; Xia XY; Luo XM; Deng YT; He SS; Mao YY; Peng XC; Wei YQ; Jiang Y
    Psychoneuroendocrinology; 2015 Feb; 52():130-42. PubMed ID: 25437118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.
    Oh H; Takagi H; Otani A; Koyama S; Kemmochi S; Uemura A; Honda Y
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):383-8. PubMed ID: 11756651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuropilin-1 and neuropilin-2 expression in the adenoma-carcinoma sequence of colorectal cancer.
    Staton CA; Koay I; Wu JM; Hoh L; Reed MW; Brown NJ
    Histopathology; 2013 May; 62(6):908-15. PubMed ID: 23551578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The green tea polyphenol EGCG potentiates the antiproliferative activity of sunitinib in human cancer cells.
    Zhou Y; Tang J; Du Y; Ding J; Liu JY
    Tumour Biol; 2016 Jul; 37(7):8555-66. PubMed ID: 26733173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sunitinib inhibits catecholamine synthesis and secretion in pheochromocytoma tumor cells by blocking VEGF receptor 2 via PLC-γ-related pathways.
    Aita Y; Ishii KA; Saito Y; Ikeda T; Kawakami Y; Shimano H; Hara H; Takekoshi K
    Am J Physiol Endocrinol Metab; 2012 Oct; 303(8):E1006-14. PubMed ID: 22912364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tyrosine kinase receptor inhibitor-targeted combined chemotherapy for metastatic bladder cancer.
    Wu CL; Ping SY; Yu CP; Yu DS
    Kaohsiung J Med Sci; 2012 Apr; 28(4):194-203. PubMed ID: 22453067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells.
    Dilwali S; Roberts D; Stankovic KM
    Cancer Biol Ther; 2015; 16(1):170-5. PubMed ID: 25692621
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting.
    Pan Q; Chathery Y; Wu Y; Rathore N; Tong RK; Peale F; Bagri A; Tessier-Lavigne M; Koch AW; Watts RJ
    J Biol Chem; 2007 Aug; 282(33):24049-56. PubMed ID: 17575273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropilin-1 enforces extracellular matrix signalling via ABL1 to promote angiogenesis.
    Raimondi C
    Biochem Soc Trans; 2014 Oct; 42(5):1429-34. PubMed ID: 25233427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.